Clinical study of patients with major depressive disorder and healthy participants to examine the usefulness of the brain network marker program using fMRI for the diagnosis and stratification of major depressive disorder

Okada Go0 sites390 target enrollmentOctober 12, 2022

Overview

No summary available.

Registry

who.int

Start Date

October 12, 2022

End Date

TBD

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Sponsor

Okada Go

•\[Patients]
•(1\)Men and women aged between 20 and 75 at the time of consent acquisition.
•(2\)Patients with major depressive disorder using M.I.N.I. measured after obtaining the consent.
•(3\)Patients who provide written and voluntary consent for participation in this study.
•\[Healthy participants]
•(1\)Men and women aged between 20 and 75 at the time of consent acquisition.
•(2\)Those whose M.I.N.I. results measured after obtaining consent are not psychiatric disorders.
•(3\)Participants who provide written and voluntary consent for participation in this study.

•\[Patients]
•(1\)Patients with mental status that makes it difficult to understand the purpose of the study.
•(2\)Patients who meet any of the following criteria:
•\-Patients with depression with psychotic features.
•\-Patients who have been diagnosed with bipolar disorder or schizophrenia using DSM\-5\.
•\-Patients who have been diagnosed with substance abuse within 6 months prior to obtaining consent.
•\-Patients who have been treated for an anxiety disorder within 6 months prior to obtaining consent.
•\-Patient who have a comorbid personality disorder at the time of consent acquisition.
•(3\)Patients with significant suicidal tendencies.
•(4\)Patients with contraindications to MRI.